Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03175224
Title	APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)
Acronym	SPARTA
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Apollomics Inc.
Indications	Advanced Solid Tumor lung non-small cell carcinoma
Therapies	Vebreltinib
Age Groups:	adult \| senior
Covered Countries	USA \| ITA \| HUN \| GBR \| FRA \| FIN \| ESP \| CAN \| AUS